TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types

Christine C Krieger1, Joseph D Perry1, Sarah J Morgan1

  • 1Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Endocrinology
|September 23, 2017
PubMed

Insights

Thyrotropin (TSH) and insulin-like growth factor-1 (IGF-1) receptor cross-talk synergistically activate ERK1/2 signaling in Graves

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Signaling

Background:

  • Thyrotropin (TSH)/insulin-like growth factor-1 (IGF-1) receptor cross-talk is implicated in Graves' orbitopathy (GO) pathogenesis.
  • TSH and IGF-1 synergistically increase hyaluronan secretion in GO orbital fibroblasts and sodium-iodide symporter expression in thyrocytes.
  • The precise mechanism of ERK1/2 activation in this synergism was previously unknown.

Purpose of the Study:

  • To investigate the role of ERK1/2 activation in the synergistic effects of TSH and IGF-1.
  • To determine if TSHR/IGF-1R cross-talk impacts ERK1/2 activation in GO fibroblasts and thyrocytes.
  • To elucidate the early signaling events involved in TSHR/IGF-1R synergism.

Main Methods:

  • Primary cultures of Graves' orbitopathy fibroblasts (GOFs) and human thyrocytes.
  • Human embryonic kidney (HEK) 293 cells overexpressing TSH receptors (HEK-TSHRs).
  • Analysis of ERK1/2 phosphorylation, pertussis toxin inhibition, and Gi/Go protein knockdown.

Main Results:

  • Simultaneous TSHR and IGF-1R activation caused rapid, synergistic ERK1/2 phosphorylation in GOFs, thyrocytes, and HEK-TSHRs.
  • This synergistic effect was partially inhibited by pertussis toxin, suggesting involvement of Gi/Go proteins.
  • Knockdown of Gi(1-3) and Go proteins inhibited TSH-stimulated ERK1/2 phosphorylation.

Conclusions:

  • TSHR/IGF-1R cross-talk triggers early synergistic ERK1/2 activation in the TSHR signaling cascade.
  • Gi/Go proteins play a role in mediating TSH-induced ERK1/2 phosphorylation.
  • This cross-talk mechanism is crucial for regulating GO fibroblasts and thyrocytes.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K